查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1866351

臨床實驗供應與物流市場－2025-2030年預測

Clinical Trial Supply and Logistics Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

臨床實驗供應和物流市場預計將從 2025 年的 53.1 億美元成長到 2030 年的 75.38 億美元，複合年成長率為 7.26%。

由於對先進藥物研發的需求不斷成長以及疾病複雜性的日益增加，全球臨床實驗供應和物流市場預計將迎來強勁成長。臨床實驗對於評估藥物安全性至關重要，需要專業的設備和後勤支援以確保結果的準確性。該市場的服務供應商在研究方法中發揮關鍵作用，他們提供必要的資源、管理試驗場地並促進患者互動。疾病盛行率的上升和對創新治療方法的需求是推動市場成長的主要因素，但高昂的初始成本和對熟練勞動力的需求構成了准入壁壘，加劇了現有企業之間的激烈競爭。

市場促進因素

醫藥研發投資快速成長

對藥物研發投入的不斷成長是臨床實驗供應和物流市場的主要驅動力。製藥公司和創業投資正將大量資金投入臨床實驗，以應對日益複雜的疾病及其不斷增加的發病率。研發活動的激增需要可靠的供應鏈來提供高品質的設備和材料，這直接推動了市場需求。全球藥物研發計劃的擴張凸顯了高效物流的重要性，以確保按時、按量、按質地交付物資，從而確保試驗順利進行。專注於開發應對新興健康挑戰的新藥，將在預測期內進一步提升市場成長前景。

缺乏替代方案鞏固了市場地位

由於缺乏可行的替代方案，供應商在臨床實驗供應物流市場的地位更加穩固。儘管一些製藥公司可能會考慮自行管理供應鏈，但確保及時、高品質交貨的高成本和風險阻​​礙了這些努力。出於降低成本和規避風險的考慮，藥物研發企業越來越依賴能夠提供臨床實驗所需專業知識和基礎設施的專業物流供應商。這種缺乏替代方案的現狀賦予了供應商強大的市場力量，使他們能夠保持競爭優勢，並充分利用日益成長的外包物流解決方案需求。

區域展望

北美和歐洲市場預計將主導全球臨床實驗供應和物流行業，這主要得益於這些地區醫藥研究機構的高度集中。先進的基礎設施、完善的法規結構以及大量的研發投入，為市場成長創造了有利環境。同時，亞太地區預計將受益於不斷成長的醫藥研究活動和不斷完善的醫療基礎設施而快速擴張。該地區的成長也得益於不斷增加的投資和有利的政策，並正逐步成為全球市場的重要貢獻者。

市場展望

受藥物研發投入不斷增加和缺乏替代解決方案的推動，臨床實驗供應和物流市場預計到2030年將顯著擴張。北美和歐洲憑藉其強大的醫藥生態系統將繼續保持主導地位，而亞太地區將成為高成長市場。儘管面臨准入門檻高、勞動力技能要求高等挑戰，但競爭激烈的市場格局及其在藥物研發中的關鍵作用確保了其強勁的成長前景。相關人員需要專注於創新和擴充性，以滿足全球臨床研究不斷變化的需求。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 全球臨床實驗供應與物流市場（依服務類型分類）

  • 介紹
  • 製造業
  • 包裝/展示
  • 貯存
  • 其他

6. 全球臨床實驗供應與物流市場（依臨床實驗階段分類）

  • 介紹
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

7. 全球臨床實驗供應與物流市場（按應用分類）

  • 介紹
  • 瘤
  • 心臟病
  • 呼吸系統疾病
  • 中樞神經系統和精神疾病
  • 其他

8. 全球臨床實驗供應和物流市場（按最終用戶分類）

  • 介紹
  • 製藥和生物技術公司
  • CRO（委外研發機構）
  • 其他

9. 全球臨床實驗供應與物流市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 台灣
    • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第11章 公司簡介

  • DHL International GmbH
  • Marken
  • Parexel International Corporation
  • Movianto
  • Catalent Inc.
  • Thermo Fisher Scientific Inc.
  • Almac Group
  • FedEx
  • PCI Pharma Service
  • Sharp Services, LLC

第12章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061611181

The Clinical Trial Supply And Logistics Market is expected to increase from USD 5.310 billion in 2025 to USD 7.538 billion in 2030, with a 7.26% CAGR.

The global clinical trial supply and logistics market is set to experience robust growth, driven by the escalating demand for advanced drug development and the increasing complexity of diseases. Clinical trials, critical for assessing drug safety, require specialized equipment and logistics support to ensure accurate outcomes. Service providers in this market supply essential resources, manage trial sites, and facilitate patient interactions, playing a pivotal role in the research process. The market is propelled by rising disease prevalence and the need for innovative treatments, though high initial costs and the need for a skilled workforce pose barriers to new entrants, fostering intense competition among established players.

Market Drivers

Surge in Drug Research Investments

The increasing investment in drug research is a primary driver of the clinical trial supply and logistics market. Pharmaceutical companies and venture capitalists are funding clinical trials to address the growing complexity and incidence of diseases. This surge in research activities necessitates reliable supply chains for high-quality equipment and materials, directly boosting market demand. The expansion of drug development projects globally underscores the need for efficient logistics to deliver supplies in the right quantity, quality, and timeframe, ensuring seamless trial execution. The focus on developing novel drugs to combat emerging health challenges further amplifies the market's growth prospects during the forecast period.

Lack of Substitutes Enhances Market Position

The absence of viable substitutes strengthens the position of vendors in the clinical trial supply and logistics market. While some pharmaceutical companies may consider managing supply chains in-house, the high costs and risks associated with ensuring timely and quality-compliant deliveries deter such efforts. The emphasis on cost reduction and risk mitigation has driven drug developers to rely on specialized logistics providers, who offer expertise and infrastructure tailored to clinical trial needs. This lack of alternatives grants suppliers significant market power, enabling them to maintain a competitive edge and capitalize on the growing demand for outsourced logistics solutions.

Geographical Outlook

The North American and European markets are expected to dominate the global clinical trial supply and logistics industry, primarily due to the high concentration of pharmaceutical research organizations in these regions. Their advanced infrastructure, regulatory frameworks, and significant R&D investments create a conducive environment for market growth. Meanwhile, the Asia Pacific region is projected to experience rapid expansion, driven by increasing pharmaceutical research activities and improving healthcare infrastructure. The region's growth is further supported by rising investments and favorable policies, positioning it as a key contributor to the global market.

Market Outlook

The clinical trial supply and logistics market is poised for significant expansion through 2030, fueled by heightened drug research investments and the absence of substitute solutions. North America and Europe will lead due to their robust pharmaceutical ecosystems, while the Asia Pacific region emerges as a high-growth market. Despite challenges like high entry barriers and workforce skill requirements, the market's competitive landscape and critical role in drug development ensure strong growth prospects. Stakeholders must focus on innovation and scalability to meet the evolving demands of global clinical research.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Service Type

  • Manufacturing
  • Packaging & Labeling
  • Storing
  • Others

By Clinical Phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4

By Application

  • Oncology
  • Cardiology
  • Respiratory Disease
  • CNS & Mental Disorders
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organization (CRO)
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY SERVICE TYPE

  • 5.1. Introduction
  • 5.2. Manufacturing
  • 5.3. Packaging & Labeling
  • 5.4. Storing
  • 5.5. Others

6. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY CLINICAL PHASE

  • 6.1. Introduction
  • 6.2. Phase 1
  • 6.3. Phase 2
  • 6.4. Phase 3
  • 6.5. Phase 4

7. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Oncology
  • 7.3. Cardiology
  • 7.4. Respiratory Disease
  • 7.5. CNS & Mental Disorders
  • 7.6. Others

8. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Contract Research Organization (CRO)
  • 8.4. Others

9. GLOBAL CLINICAL TRIAL SUPPLY AND LOGISTICS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Italy
    • 9.4.5. Spain
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Taiwan
    • 9.6.8. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. DHL International GmbH
  • 11.2. Marken
  • 11.3. Parexel International Corporation
  • 11.4. Movianto
  • 11.5. Catalent Inc.
  • 11.6. Thermo Fisher Scientific Inc.
  • 11.7. Almac Group
  • 11.8. FedEx
  • 11.9. PCI Pharma Service
  • 11.10. Sharp Services, LLC

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations